Bavarian Nordic: State gains from vaccine support capped by contract

Bavarian Nordic's potential corona vaccine will not be a gold mine investment for the Danish state, the biotech company's CFO says, as their agreement includes a cap on royalties.
Photo: LISELOTTE SABROE
Photo: LISELOTTE SABROE
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT

After obtaining EUR 108m (DKK 800m) in financial aid from the Danish state, Bavarian Nordic has the opportunity to create a lucrative business before the state wants any of that money back.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading